Conexiant
Login
  • The Analytical Scientist
  • The Cannabis Scientist
  • The Medicine Maker
  • The Ophthalmologist
  • The Pathologist
  • The Traditional Scientist
The Analytical Scientist
  • Explore

    Explore

    • Latest
    • News & Research
    • Trends & Challenges
    • Keynote Interviews
    • Opinion & Personal Narratives
    • Product Profiles
    • App Notes
    • The Product Book

    Featured Topics

    • Mass Spectrometry
    • Chromatography
    • Spectroscopy

    Issues

    • Latest Issue
    • Archive
  • Topics

    Techniques & Tools

    • Mass Spectrometry
    • Chromatography
    • Spectroscopy
    • Microscopy
    • Sensors
    • Data and AI

    • View All Topics

    Applications & Fields

    • Clinical
    • Environmental
    • Food, Beverage & Agriculture
    • Pharma and Biopharma
    • Omics
    • Forensics
  • People & Profiles

    People & Profiles

    • Power List
    • Voices in the Community
    • Sitting Down With
    • Authors & Contributors
  • Business & Education

    Business & Education

    • Innovation
    • Business & Entrepreneurship
    • Career Pathways
  • Events
    • Live Events
    • Webinars
  • Multimedia
    • Video
    • Content Hubs
Subscribe
Subscribe

False

The Analytical Scientist / Issues / 2026 / June / Taming “The Monster” – with Koen Sandra
Pharma and Biopharma Keynote Interviews

Taming “The Monster” – with Koen Sandra

Ahead of ISC2026 in Prague, Koen Sandra explores how analytical scientists are rising to the challenge posed by increasingly intimidating biotherapeutics

06/09/2026 11 min read
  • Full Article
  • Summary
  • Listen
  • Report
  • Scorecard
  • Quiz
  • Top Institutions

Share

Clinical Scorecard: Taming “The Monster” – with Koen Sandra

At a Glance

CategoryDetail
Condition
Key Mechanisms
Target PopulationAnalytical scientists and biopharmaceutical researchers focusing on complex therapeutics.
Care Setting

Key Highlights

  • Focus on complex biotherapeutics including antibody-oligonucleotide conjugates and their analytical challenges.

Guideline-Based Recommendations

Diagnosis

  • Consider molecular characterization techniques for accurate diagnosis.

Management

  • Implement integrated analytical workflows for managing complex biotherapeutics.

Monitoring & Follow-up

  • Regularly assess the stability and efficacy of biopharmaceuticals using advanced analytics.

Risks

  • Identify potential analytical pitfalls in characterizing novel biotherapeutics.

Patient & Prescribing Data

Patients receiving biopharmaceutical therapies requiring complex analytical characterization.

Clinical Best Practices

  • Utilize orthogonal, high-resolution analytics for complex molecules, such as LC-MS and NMR.
  • Consolidate multiple assays into single platforms for efficiency, improving throughput and reducing costs.
  • Engage in continuous knowledge sharing and collaboration among scientists to foster innovation.

Related Resources & Content

    This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.

    Newsletters

    Receive the latest analytical science news, personalities, education, and career development – weekly to your inbox.

    Newsletter Signup Image

    False

    Advertisement

    Recommended

    False

    Related Content

    Loading the Molecular Dice
    Pharma and Biopharma
    Loading the Molecular Dice

    December 12, 2024

    2 min read

    How a framework for controlling molecular reactions at the atomic scale has potential implications for nanotechnology, pharmaceutical synthesis, and clean energy research

    CD-MS: To Megadalton and Beyond
    Pharma and Biopharma
    CD-MS: To Megadalton and Beyond

    October 1, 2024

    10 min read

    Charge-detection mass spectrometry (CD-MS) has extended the range of MS to gigadalton-sized viruses and polymers; and with a commercial instrument in development and exciting new applications in complex protein mixtures, maturity beckons

    New NMR Technique Enables Direct Detection of Molecular Chirality
    Pharma and Biopharma
    New NMR Technique Enables Direct Detection of Molecular Chirality

    October 1, 2024

    1 min read

    Researchers develop an NMR method to distinguish between enantiomers without the need for chiral agents

    Mass Spec Imaging Meets Proteomics
    Pharma and Biopharma
    Mass Spec Imaging Meets Proteomics

    October 2, 2024

    2 min read

    Researchers combine tissue imaging with proteomics to shed light on the neurotoxic effects associated with HIV medication Efavirenz treatment

    Affiliations:

    Specialties:

    Areas of Expertise:

    Contributions:

    False

    The Analytical Scientist
    Subscribe

    About

    • About Us
    • Work at Conexiant Europe
    • Terms and Conditions
    • Privacy Policy
    • Advertise With Us
    • Contact Us

    Copyright © 2026 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.